{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:10:04Z","timestamp":1792091404454,"version":"4.4.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302153\/2019-5"],"award-info":[{"award-number":["302153\/2019-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11033-021-06672-8","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T19:18:43Z","timestamp":1629487123000},"page":"6619-6629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis"],"prefix":"10.1007","volume":"48","author":[{"given":"Fernanda Rocha Chaves","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Almeida","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e1dia Eliza","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Augusta Duarte","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-3882","authenticated-orcid":false,"given":"Ana Cristina","family":"Sim\u00f5es e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"6672_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.amjms.2019.10.014","volume":"359","author":"Y Wu","year":"2020","unstructured":"Wu Y, Li M, Zeng J et al (2020) Differential expression of renin-angiotensin system-related components in patients with rheumatoid arthritis and osteoarthritis. Am J Med Sci 359:17\u201326. https:\/\/doi.org\/10.1016\/j.amjms.2019.10.014","journal-title":"Am J Med Sci"},{"key":"6672_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semarthrit.2014.05.001","volume":"44","author":"F Matcham","year":"2014","unstructured":"Matcham F, Scott IC, Rayner L et al (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum 44:123\u2013130. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.001","journal-title":"Semin Arthritis Rheum"},{"key":"6672_CR3","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160727142401","author":"TRR Prestes","year":"2017","unstructured":"Prestes TRR, Rocha NP, Miranda AS, Teixeira AL (2017) The anti-inflammatory potential of ACE2\/angiotensin-(1\u20137)\/mas receptor axis: evidence from basic and clinical research. CDT. https:\/\/doi.org\/10.2174\/1389450117666160727142401","journal-title":"CDT"},{"issue":"10","key":"6672_CR4","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/art.24844","volume":"60","author":"MJ del Rey","year":"2009","unstructured":"del Rey MJ, Izquierdo E, Caja S et al (2009) Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1\/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 60(10):2926\u20132934. https:\/\/doi.org\/10.1002\/art.24844","journal-title":"Arthritis Rheum"},{"key":"6672_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8515-6","volume":"51","author":"R Baum","year":"2016","unstructured":"Baum R, Gravallese EM (2016) Bone as a target organ in rheumatic disease: impact on osteoclasts and osteoblasts. Clin Rev Allergy Immunol 51:1\u201315. https:\/\/doi.org\/10.1007\/s12016-015-8515-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"6672_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0084-3873(08)79100-4","volume":"2008","author":"SM Berney","year":"2008","unstructured":"Berney SM (2008) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Year b med 2008:16\u201318. https:\/\/doi.org\/10.1016\/s0084-3873(08)79100-4","journal-title":"Year b med"},{"key":"6672_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00296-004-0564-8","volume":"25","author":"V Cobankara","year":"2005","unstructured":"Cobankara V, Ozt\u00fcrk MA, Kiraz S et al (2005) Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis. Rheumatol Int 25:285\u2013291. https:\/\/doi.org\/10.1007\/s00296-004-0564-8","journal-title":"Rheumatol Int"},{"key":"6672_CR8","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.2147\/TCRM.S174693","volume":"14","author":"NMA Mahmood","year":"2018","unstructured":"Mahmood NMA, Hussain SA, Mirza RR (2018) Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study. Ther Clin Risk Manag 14:1379\u20131385. https:\/\/doi.org\/10.2147\/TCRM.S174693","journal-title":"Ther Clin Risk Manag"},{"key":"6672_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1161\/01.RES.0000115557.25127.8D","volume":"94","author":"S Wassmann","year":"2004","unstructured":"Wassmann S, Stumpf M, Strehlow K et al (2004) Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94:534\u2013541. https:\/\/doi.org\/10.1161\/01.RES.0000115557.25127.8D","journal-title":"Circ Res"},{"key":"6672_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105703","volume":"121","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ding H, Song Q et al (2020) Angiotensin II inhibits osteogenic differentiation of isolated synoviocytes by increasing DKK-1 expression. Int J Biochem Cell Biol 121:105703. https:\/\/doi.org\/10.1016\/j.biocel.2020.105703","journal-title":"Int J Biochem Cell Biol"},{"key":"6672_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.peptides.2013.05.012","volume":"46","author":"KD Silveira","year":"2013","unstructured":"Silveira KD, Coelho FM, Vieira AT et al (2013) Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis. Peptides 46:53\u201363. https:\/\/doi.org\/10.1016\/j.peptides.2013.05.012","journal-title":"Peptides"},{"key":"6672_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/ard.59.2.125","volume":"59","author":"DA Walsh","year":"2000","unstructured":"Walsh DA, Catravas J, Wharton J (2000) Angiotensin converting enzyme in human synovium: increased stromal [(125)I]351A binding in rheumatoid arthritis. Ann Rheum Dis 59:125\u2013131. https:\/\/doi.org\/10.1136\/ard.59.2.125","journal-title":"Ann Rheum Dis"},{"key":"6672_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/rheumatology\/31.8.509","volume":"31","author":"KD Bhoola","year":"1992","unstructured":"Bhoola KD, Elson CJ, Dieppe PA (1992) Kinins\u2014key mediators in inflammatory arthritis? Rheumatology 31:509\u2013518","journal-title":"Rheumatology"},{"key":"6672_CR14","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/art.21040","volume":"52","author":"K Sagawa","year":"2005","unstructured":"Sagawa K, Nagatani K, Komagata Y, Yamamoto K (2005) Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice. Arthritis Rheum 52:1920\u20131928. https:\/\/doi.org\/10.1002\/art.21040","journal-title":"Arthritis Rheum"},{"key":"6672_CR15","first-page":"632","volume":"20","author":"A Guy","year":"2018","unstructured":"Guy A, Sharif K, Bragazzi NL et al (2018) Low levels of renin and high aldosterone-to-renin ratio among rheumatoid patients and ankylosing spondylitis patients: a prospective study. Isr Med Assoc J 20:632\u2013636","journal-title":"Isr Med Assoc J"},{"key":"6672_CR16","doi-asserted-by":"publisher","first-page":"13293","DOI":"10.1038\/s41598-017-13746-w","volume":"7","author":"R Terenzi","year":"2017","unstructured":"Terenzi R, Manetti M, Rosa I et al (2017) Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium. Sci Rep 7:13293. https:\/\/doi.org\/10.1038\/s41598-017-13746-w","journal-title":"Sci Rep"},{"key":"6672_CR17","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","volume":"26","author":"UM Steckelings","year":"2005","unstructured":"Steckelings UM, Kaschina E, Unger T (2005) The AT2 receptor\u2013a matter of love and hate. Peptides 26:1401\u20131409. https:\/\/doi.org\/10.1016\/j.peptides.2005.03.010","journal-title":"Peptides"},{"key":"6672_CR18","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/jcmm.12128","volume":"17","author":"D Wang","year":"2013","unstructured":"Wang D, Hu S, Zhu J et al (2013) Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis. J Cell Mol Med 17:1577\u20131587. https:\/\/doi.org\/10.1111\/jcmm.12128","journal-title":"J Cell Mol Med"},{"key":"6672_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bph.13063","volume":"173","author":"AK Sampson","year":"2016","unstructured":"Sampson AK, Irvine JC, Shihata WA et al (2016) Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. Br J Pharmacol 173:729\u2013740. https:\/\/doi.org\/10.1111\/bph.13063","journal-title":"Br J Pharmacol"},{"key":"6672_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai M, Horiuchi M (2009) Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1\u20137)-mas receptor axis. Hypertens Res 32:533\u2013536. https:\/\/doi.org\/10.1038\/hr.2009.74","journal-title":"Hypertens Res"},{"key":"6672_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ijcard.2015.03.059","volume":"184","author":"J Yang","year":"2015","unstructured":"Yang J, Yang X, Meng X et al (2015) Endogenous activated angiotensin-(1\u20137) plays a protective effect against atherosclerotic plaques unstability in high fat diet fed ApoE knockout mice. Int J Cardiol 184:645\u2013652. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.059","journal-title":"Int J Cardiol"},{"key":"6672_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1164\/rccm.200811-1678OC","volume":"179","author":"AJ Ferreira","year":"2009","unstructured":"Ferreira AJ, Shenoy V, Yamazato Y et al (2009) Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. Am J Respir Crit Care Med 179:1048\u20131054. https:\/\/doi.org\/10.1164\/rccm.200811-1678OC","journal-title":"Am J Respir Crit Care Med"},{"key":"6672_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.freeradbiomed.2013.08.183","volume":"65","author":"ED Moore","year":"2013","unstructured":"Moore ED, Kooshki M, Metheny-Barlow LJ et al (2013) Angiotensin-(1\u20137) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling. Free Radic Biol Med 65:1060\u20131068. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.08.183","journal-title":"Free Radic Biol Med"},{"key":"6672_CR24","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","volume":"167","author":"T Jiang","year":"2012","unstructured":"Jiang T, Gao L, Guo J et al (2012) Suppressing inflammation by inhibiting the NF-\u03baB pathway contributes to the neuroprotective effect of angiotensin-(1\u20137) in rats with permanent cerebral ischaemia: effect of Ang-(1\u20137) on neuroinflammation. Br J Pharmacol 167:1520\u20131532. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02105.x","journal-title":"Br J Pharmacol"},{"key":"6672_CR25","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","volume":"185","author":"KD da Silveira","year":"2010","unstructured":"da Silveira KD, Coelho FM, Vieira AT et al (2010) Anti-inflammatory effects of the activation of the angiotensin-(1\u20137) receptor, mas, in experimental models of arthritis. J Immunol 185:5569\u20135576. https:\/\/doi.org\/10.4049\/jimmunol.1000314","journal-title":"J Immunol"},{"key":"6672_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/14397595.2020.1740418","volume":"31","author":"NFT Braz","year":"2021","unstructured":"Braz NFT, Pinto MRC, Vieira \u00c9LM et al (2021) Renin-angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis. Mod Rheumatol 31:119\u2013126. https:\/\/doi.org\/10.1080\/14397595.2020.1740418","journal-title":"Mod Rheumatol"},{"key":"6672_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3904\/kjim.2010.25.4.429","volume":"25","author":"S-J Moon","year":"2010","unstructured":"Moon S-J, Park M-K, Oh H-J et al (2010) Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts. Korean J Intern Med 25:429\u2013435. https:\/\/doi.org\/10.3904\/kjim.2010.25.4.429","journal-title":"Korean J Intern Med"},{"key":"6672_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023540","volume":"6","author":"T Saber","year":"2011","unstructured":"Saber T, Veale DJ, Balogh E et al (2011) Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis. PLoS ONE 6:e23540. https:\/\/doi.org\/10.1371\/journal.pone.0023540","journal-title":"PLoS ONE"},{"key":"6672_CR29","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.4049\/jimmunol.0902941","volume":"184","author":"M Connolly","year":"2010","unstructured":"Connolly M, Marrelli A, Blades M et al (2010) Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis\/SCID mouse chimera model. J Immunol 184:6427\u20136437. https:\/\/doi.org\/10.4049\/jimmunol.0902941","journal-title":"J Immunol"},{"key":"6672_CR30","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1136\/ard.2009.127241","volume":"69","author":"MA Amin","year":"2010","unstructured":"Amin MA, Rabquer BJ, Mansfield PJ et al (2010) Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases. Ann Rheum Dis 69:2204\u20132212. https:\/\/doi.org\/10.1136\/ard.2009.127241","journal-title":"Ann Rheum Dis"},{"key":"6672_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1759720X18776224","volume":"10","author":"CJ Malemud","year":"2018","unstructured":"Malemud CJ (2018) The role of the JAK\/STAT signal pathway in rheumatoid arthritis. Ther Adv Musculoskelet Dis 10:117\u2013127. https:\/\/doi.org\/10.1177\/1759720X18776224","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"6672_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jcp.26580","volume":"234","author":"S Ni","year":"2018","unstructured":"Ni S, Li C, Xu N et al (2018) Follistatin-like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK\/STAT3 and NF-\u03baB pathways. J Cell Physiol 234:454\u2013463. https:\/\/doi.org\/10.1002\/jcp.26580","journal-title":"J Cell Physiol"},{"key":"6672_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00011-015-0905-y","volume":"65","author":"C-H Li","year":"2016","unstructured":"Li C-H, Xu L-L, Zhao J-X et al (2016) CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2\/STAT3 and p38\/MAPK signaling pathway. Inflamm Res 65:193\u2013202. https:\/\/doi.org\/10.1007\/s00011-015-0905-y","journal-title":"Inflamm Res"},{"key":"6672_CR34","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/ar2689","volume":"11","author":"MA Akhavani","year":"2009","unstructured":"Akhavani MA, Madden L, Buysschaert I et al (2009) Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther 11:R64. https:\/\/doi.org\/10.1186\/ar2689","journal-title":"Arthritis Res Ther"},{"key":"6672_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","volume":"23","author":"DJ Hicklin","year":"2005","unstructured":"Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011\u20131027. https:\/\/doi.org\/10.1200\/JCO.2005.06.081","journal-title":"J Clin Oncol"},{"key":"6672_CR36","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD et al (2018) Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev 98:1627\u20131738. https:\/\/doi.org\/10.1152\/physrev.00038.2017","journal-title":"Physiol Rev"},{"key":"6672_CR37","first-page":"141","volume":"105","author":"LA Fernandez","year":"1985","unstructured":"Fernandez LA, Twickler J, Mead A (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105:141\u2013145","journal-title":"J Lab Clin Med"},{"key":"6672_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1549-8719.2001.tb00158.x","volume":"8","author":"SL Amaral","year":"2001","unstructured":"Amaral SL, Linderman JR, Morse MM, Greene AS (2001) Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8:57\u201367. https:\/\/doi.org\/10.1111\/j.1549-8719.2001.tb00158.x","journal-title":"Microcirculation"},{"key":"6672_CR39","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1158\/1535-7163.MCT-09-0161","volume":"8","author":"DR Soto-Pantoja","year":"2009","unstructured":"Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA (2009) Angiotensin-(1\u20137) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther 8:1676\u20131683. https:\/\/doi.org\/10.1158\/1535-7163.MCT-09-0161","journal-title":"Mol Cancer Ther"},{"key":"6672_CR40","doi-asserted-by":"publisher","first-page":"88475","DOI":"10.18632\/oncotarget.19290","volume":"8","author":"N Cambados","year":"2017","unstructured":"Cambados N, Walther T, Nahmod K et al (2017) Angiotensin-(1\u20137) counteracts the transforming effects triggered by angiotensin II in breast cancer cells. Oncotarget 8:88475\u201388487. https:\/\/doi.org\/10.18632\/oncotarget.19290","journal-title":"Oncotarget"},{"key":"6672_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1359\/jbmr.081006","volume":"24","author":"Y Asaba","year":"2009","unstructured":"Asaba Y, Ito M, Fumoto T et al (2009) Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24:241\u2013250. https:\/\/doi.org\/10.1359\/jbmr.081006","journal-title":"J Bone Miner Res"},{"key":"6672_CR42","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jsps.2020.07.011","volume":"28","author":"AA Azouz","year":"2020","unstructured":"Azouz AA, Saleh E, Abo-Saif AA (2020) Aliskiren, tadalafil, and cinnamaldehyde alleviate joint destruction biomarkers; MMP-3 and RANKL; in complete Freund\u2019s adjuvant arthritis model: downregulation of IL-6\/JAK2\/STAT3 signaling pathway. Saudi Pharm J 28:1101\u20131111. https:\/\/doi.org\/10.1016\/j.jsps.2020.07.011","journal-title":"Saudi Pharm J"},{"key":"6672_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","volume":"233","author":"NC Walsh","year":"2010","unstructured":"Walsh NC, Gravallese EM (2010) Bone remodeling in rheumatic disease: a question of balance. Immunol Rev 233:301\u2013312. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00857.x","journal-title":"Immunol Rev"},{"key":"6672_CR44","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.intimp.2018.11.001","volume":"65","author":"Y Wang","year":"2018","unstructured":"Wang Y, Kou J, Zhang H et al (2018) The renin-angiotensin system in the synovium promotes periarticular osteopenia in a rat model of collagen-induced arthritis. Int Immunopharmacol 65:550\u2013558. https:\/\/doi.org\/10.1016\/j.intimp.2018.11.001","journal-title":"Int Immunopharmacol"},{"key":"6672_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114145","author":"T Akagi","year":"2020","unstructured":"Akagi T, Mukai T, Mito T et al (2020) Effect of angiotensin II on bone erosion and systemic bone loss in mice with tumor necrosis factor-mediated arthritis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21114145","journal-title":"Int J Mol Sci"},{"key":"6672_CR46","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s10067-017-3570-4","volume":"36","author":"A Boman","year":"2017","unstructured":"Boman A, Kokkonen H, \u00c4rlestig L et al (2017) Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis. Clin Rheumatol 36:1005\u20131012. https:\/\/doi.org\/10.1007\/s10067-017-3570-4","journal-title":"Clin Rheumatol"},{"key":"6672_CR47","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2","volume":"43","author":"EM Gravallese","year":"2000","unstructured":"Gravallese EM, Manning C, Tsay A et al (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250\u2013258. https:\/\/doi.org\/10.1002\/1529-0131(200002)43:2","journal-title":"Arthritis Rheum"},{"key":"6672_CR48","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","volume":"75","author":"L Danks","year":"2016","unstructured":"Danks L, Komatsu N, Guerrini MM et al (2016) RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann Rheum Dis 75:1187\u20131195. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207137","journal-title":"Ann Rheum Dis"},{"key":"6672_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","volume":"43","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Iizuka H, Juji T et al (2000) Involvement of receptor activator of nuclear factor kappaB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43:259\u2013269. https:\/\/doi.org\/10.1002\/1529-0131(200002)43:2%3c259::AID-ANR4%3e3.0.CO;2-W","journal-title":"Arthritis Rheum"},{"key":"6672_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1677\/joe.0.1520005","volume":"152","author":"R Hatton","year":"1997","unstructured":"Hatton R, Stimpel M, Chambers TJ (1997) Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 152:5\u201310. https:\/\/doi.org\/10.1677\/joe.0.1520005","journal-title":"J Endocrinol"},{"key":"6672_CR51","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu H, Nakagami H, Osako MK et al (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22:2465\u20132475. https:\/\/doi.org\/10.1096\/fj.07-098954","journal-title":"FASEB J"},{"key":"6672_CR52","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00198-016-3769-2","volume":"28","author":"CAF Zerbini","year":"2017","unstructured":"Zerbini CAF, Clark P, Mendez-Sanchez L et al (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28:429\u2013446. https:\/\/doi.org\/10.1007\/s00198-016-3769-2","journal-title":"Osteoporos Int"},{"key":"6672_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14397595.2017.1369491","volume":"28","author":"S Tanaka","year":"2018","unstructured":"Tanaka S, Tanaka Y, Ishiguro N et al (2018) RANKL: a therapeutic target for bone destruction in rheumatoid arthritis. Modern Rheumatol 28:9\u201316. https:\/\/doi.org\/10.1080\/14397595.2017.1369491","journal-title":"Modern Rheumatol"},{"key":"6672_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/34848","volume":"391","author":"A Glinka","year":"1998","unstructured":"Glinka A, Wu W, Delius H et al (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357\u2013362. https:\/\/doi.org\/10.1038\/34848","journal-title":"Nature"},{"key":"6672_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225525","author":"K Maeda","year":"2019","unstructured":"Maeda K, Kobayashi Y, Koide M et al (2019) The regulation of bone metabolism and disorders by Wnt signaling. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20225525","journal-title":"Int J Mol Sci"},{"key":"6672_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.2653","volume":"18","author":"K Maeda","year":"2012","unstructured":"Maeda K, Kobayashi Y, Udagawa N et al (2012) Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med 18:405\u2013412. https:\/\/doi.org\/10.1038\/nm.2653","journal-title":"Nat Med"},{"key":"6672_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0002-9440(10)62957-4","volume":"167","author":"Y Nakamura","year":"2005","unstructured":"Nakamura Y, Nawata M, Wakitani S (2005) Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 167:97\u2013105. https:\/\/doi.org\/10.1016\/S0002-9440(10)62957-4","journal-title":"Am J Pathol"},{"key":"6672_CR58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nm1538","volume":"13","author":"D Diarra","year":"2007","unstructured":"Diarra D, Stolina M, Polzer K et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13:156\u2013163. https:\/\/doi.org\/10.1038\/nm1538","journal-title":"Nat Med"},{"key":"6672_CR59","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1359\/jbmr.090320","volume":"24","author":"NC Walsh","year":"2009","unstructured":"Walsh NC, Reinwald S, Manning CA et al (2009) Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res 24:1572\u20131585. https:\/\/doi.org\/10.1359\/jbmr.090320","journal-title":"J Bone Miner Res"},{"key":"6672_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1681\/ASN.2014010085","volume":"26","author":"L Zhou","year":"2015","unstructured":"Zhou L, Li Y, Hao S et al (2015) Multiple genes of the renin-angiotensin system are novel targets of Wnt\/\u03b2-catenin signaling. J Am Soc Nephrol 26:107\u2013120. https:\/\/doi.org\/10.1681\/ASN.2014010085","journal-title":"J Am Soc Nephrol"},{"key":"6672_CR61","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00774-015-0700-4","volume":"34","author":"Q Wu","year":"2016","unstructured":"Wu Q, Xiong X, Zhang X et al (2016) Secondary osteoporosis in collagen-induced arthritis rats. J Bone Miner Metab 34:500\u2013516. https:\/\/doi.org\/10.1007\/s00774-015-0700-4","journal-title":"J Bone Miner Metab"},{"key":"6672_CR62","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2741\/1915","volume":"11","author":"CJ Malemud","year":"2006","unstructured":"Malemud CJ (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11:1696\u20131701. https:\/\/doi.org\/10.2741\/1915","journal-title":"Front Biosci"},{"key":"6672_CR63","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.2741\/1912","volume":"11","author":"A Nakashima","year":"2006","unstructured":"Nakashima A, Tamura M (2006) Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation. Front Biosci 11:1667\u20131678. https:\/\/doi.org\/10.2741\/1912","journal-title":"Front Biosci"},{"key":"6672_CR64","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.immuni.2006.12.007","volume":"26","author":"B Wu","year":"2007","unstructured":"Wu B, Crampton SP, Hughes CCW (2007) Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26:227\u2013239. https:\/\/doi.org\/10.1016\/j.immuni.2006.12.007","journal-title":"Immunity"},{"key":"6672_CR65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/1756-185X.12434","volume":"19","author":"SMA Galil","year":"2016","unstructured":"Galil SMA, El-Shafey AM, Hagrass HA et al (2016) Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients. Int J Rheum Dis 19:377\u2013384. https:\/\/doi.org\/10.1111\/1756-185X.12434","journal-title":"Int J Rheum Dis"},{"key":"6672_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000215.75","author":"P Pandey","year":"2017","unstructured":"Pandey P, Bhatt PC, Kumar V (2017) 75 Moringa oleifera lam ameliorates adjuvant induced arthritis via inhibition of inflammatory mediators and down-regulation of mmp3 and mmp-9 proteins. Lupus Sci Med. https:\/\/doi.org\/10.1136\/lupus-2017-000215.75","journal-title":"Lupus Sci Med"},{"key":"6672_CR67","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.biochi.2012.12.016","volume":"95","author":"K Nakai","year":"2013","unstructured":"Nakai K, Kawato T, Morita T et al (2013) Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT(1) receptor in osteoblasts. Biochimie 95:922\u2013933. https:\/\/doi.org\/10.1016\/j.biochi.2012.12.016","journal-title":"Biochimie"},{"key":"6672_CR68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pros.22542","volume":"73","author":"B Krishnan","year":"2013","unstructured":"Krishnan B, Smith TL, Dubey P et al (2013) Angiotensin-(1\u20137) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate 73:71\u201382. https:\/\/doi.org\/10.1002\/pros.22542","journal-title":"Prostate"},{"key":"6672_CR69","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1152\/ajpendo.00158.2020","volume":"320","author":"N-N Sha","year":"2021","unstructured":"Sha N-N, Zhang J-L, Poon CC-W et al (2021) Differential responses of bone to angiotensin II and angiotensin(1\u20137): beneficial effects of ANG(1\u20137) on bone with exposure to high glucose. Am J Physiol Endocrinol Metab 320:E55\u2013E70. https:\/\/doi.org\/10.1152\/ajpendo.00158.2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6672_CR70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/biof.1241","volume":"41","author":"V Deepak","year":"2015","unstructured":"Deepak V, Kruger MC, Joubert A, Coetzee M (2015) Piperine alleviates osteoclast formation through the p38\/c-Fos\/NFATc1 signaling axis. BioFactors 41:403\u2013413. https:\/\/doi.org\/10.1002\/biof.1241","journal-title":"BioFactors"},{"key":"6672_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111800","volume":"387","author":"S Zhang","year":"2020","unstructured":"Zhang S, Li H, Tang H et al (2020) Felodipine blocks osteoclast differentiation and ameliorates estrogen-dependent bone loss in mice by modulating p38 signaling pathway. Exp Cell Res 387:111800. https:\/\/doi.org\/10.1016\/j.yexcr.2019.111800","journal-title":"Exp Cell Res"},{"key":"6672_CR72","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molimm.2008.10.022","volume":"46","author":"W Nie","year":"2009","unstructured":"Nie W, Yan H, Li S et al (2009) Angiotensin-(1\u20137) enhances angiotensin II induced phosphorylation of ERK1\/2 in mouse bone marrow-derived dendritic cells. Mol Immunol 46:355\u2013361. https:\/\/doi.org\/10.1016\/j.molimm.2008.10.022","journal-title":"Mol Immunol"},{"key":"6672_CR73","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biopha.2017.05.062","volume":"92","author":"HM Abuohashish","year":"2017","unstructured":"Abuohashish HM, Ahmed MM, Sabry D et al (2017) ACE-2\/Ang1-7\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats. Biomed Pharmacother 92:58\u201368. https:\/\/doi.org\/10.1016\/j.biopha.2017.05.062","journal-title":"Biomed Pharmacother"},{"key":"6672_CR74","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1210\/er.2007-0038","volume":"29","author":"J Lorenzo","year":"2008","unstructured":"Lorenzo J, Horowitz M, Choi Y (2008) Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29:403\u2013440. https:\/\/doi.org\/10.1210\/er.2007-0038","journal-title":"Endocr Rev"},{"key":"6672_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.abb.2010.05.027","volume":"503","author":"R Pacifici","year":"2010","unstructured":"Pacifici R (2010) The immune system and bone. Arch Biochem Biophys 503:41\u201353. https:\/\/doi.org\/10.1016\/j.abb.2010.05.027","journal-title":"Arch Biochem Biophys"},{"key":"6672_CR76","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1182\/blood.V77.8.1627.1627","volume":"77","author":"CA Dinarello","year":"1991","unstructured":"Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627\u20131652. https:\/\/doi.org\/10.1182\/blood.V77.8.1627.1627","journal-title":"Blood"},{"key":"6672_CR77","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/excr.1998.4320","volume":"247","author":"E Jimi","year":"1999","unstructured":"Jimi E, Nakamura I, Duong LT et al (1999) Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts\/stromal cells. Exp Cell Res 247:84\u201393. https:\/\/doi.org\/10.1006\/excr.1998.4320","journal-title":"Exp Cell Res"},{"key":"6672_CR78","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s8756-3282(99)00162-3","volume":"25","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC, Lacey DL, Dunstan CR et al (1999) Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25:255\u2013259. https:\/\/doi.org\/10.1016\/s8756-3282(99)00162-3","journal-title":"Bone"},{"key":"6672_CR79","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.4049\/jimmunol.169.6.3353","volume":"169","author":"P Palmqvist","year":"2002","unstructured":"Palmqvist P, Persson E, Conaway HH, Lerner UH (2002) IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 169:3353\u20133362. https:\/\/doi.org\/10.4049\/jimmunol.169.6.3353","journal-title":"J Immunol"},{"key":"6672_CR80","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.bone.2005.06.002","volume":"37","author":"N Franchimont","year":"2005","unstructured":"Franchimont N, Wertz S, Malaise M (2005) Interleukin-6: an osteotropic factor influencing bone formation? Bone 37:601\u2013606. https:\/\/doi.org\/10.1016\/j.bone.2005.06.002","journal-title":"Bone"},{"key":"6672_CR81","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","volume":"145","author":"Y Ishimi","year":"1990","unstructured":"Ishimi Y, Miyaura C, Jin CH et al (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297\u20133303","journal-title":"J Immunol"},{"key":"6672_CR82","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1210\/endo.139.10.6247","volume":"139","author":"L Rothe","year":"1998","unstructured":"Rothe L, Collin-Osdoby P, Chen Y et al (1998) Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology 139:4353\u20134363. https:\/\/doi.org\/10.1210\/endo.139.10.6247","journal-title":"Endocrinology"},{"key":"6672_CR83","doi-asserted-by":"publisher","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","volume":"65","author":"MS Bendre","year":"2005","unstructured":"Bendre MS, Margulies AG, Walser B et al (2005) Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res 65:11001\u201311009. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2630","journal-title":"Cancer Res"},{"key":"6672_CR84","doi-asserted-by":"publisher","first-page":"11846","DOI":"10.1074\/jbc.M512624200","volume":"281","author":"Z Yao","year":"2006","unstructured":"Yao Z, Li P, Zhang Q et al (2006) Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem 281:11846\u201311855. https:\/\/doi.org\/10.1074\/jbc.M512624200","journal-title":"J Biol Chem"},{"key":"6672_CR85","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE et al (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481\u20131488. https:\/\/doi.org\/10.1172\/JCI11176","journal-title":"J Clin Invest"},{"key":"6672_CR86","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0006-291X(02)00855-0","volume":"296","author":"N Lapteva","year":"2002","unstructured":"Lapteva N, Ide K, Nieda M et al (2002) Activation and suppression of renin\u2013angiotensinsystem inhumandendriticcells. Biochem Biophys Res Commun 296:194\u2013200","journal-title":"Biochem Biophys Res Commun"},{"key":"6672_CR87","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1046\/j.1523-1755.2002.00452.x","volume":"62","author":"FS Shihab","year":"2002","unstructured":"Shihab FS, Bennett WM, Isaac J et al (2002) Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR\/Flk-1 in cyclosporine nephrotoxicity. Kidney Int 62:422\u2013433. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00452.x","journal-title":"Kidney Int"},{"key":"6672_CR88","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1007\/s10495-017-1420-0","volume":"22","author":"J-Y Liu","year":"2017","unstructured":"Liu J-Y, Hou Y-L, Cao R et al (2017) Protodioscin ameliorates oxidative stress, inflammation and histology outcome in complete Freund\u2019s adjuvant induced arthritis rats. Apoptosis 22:1454\u20131460. https:\/\/doi.org\/10.1007\/s10495-017-1420-0","journal-title":"Apoptosis"},{"key":"6672_CR89","first-page":"168","volume":"65","author":"H Tian","year":"2007","unstructured":"Tian H, Cronstein BN (2007) Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis 65:168\u2013173","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"6672_CR90","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"JAM Wessels","year":"2008","unstructured":"Wessels JAM, Huizinga TWJ, Guchelaar H-J (2008) Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology 47:249\u2013255. https:\/\/doi.org\/10.1093\/rheumatology\/kem279","journal-title":"Rheumatology"},{"key":"6672_CR91","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ejphar.2012.10.024","volume":"698","author":"R Refaat","year":"2013","unstructured":"Refaat R, Salama M, Abdel Meguid E et al (2013) Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats. Eur J Pharmacol 698:421\u2013428. https:\/\/doi.org\/10.1016\/j.ejphar.2012.10.024","journal-title":"Eur J Pharmacol"},{"key":"6672_CR92","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10787-018-0545-2","volume":"27","author":"X Wang","year":"2019","unstructured":"Wang X, Chen X, Huang W et al (2019) Losartan suppresses the inflammatory response in collagen-induced arthritis by inhibiting the MAPK and NF-\u03baB pathways in B and T cells. Inflammopharmacology 27:487\u2013502. https:\/\/doi.org\/10.1007\/s10787-018-0545-2","journal-title":"Inflammopharmacology"},{"key":"6672_CR93","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/pds.3291","volume":"21","author":"HJI de Jong","year":"2012","unstructured":"de Jong HJI, Vandebriel RJ, Saldi SRF et al (2012) Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users. Pharmacoepidemiol Drug Saf 21:835\u2013843. https:\/\/doi.org\/10.1002\/pds.3291","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6672_CR94","first-page":"593","volume":"32","author":"AG Gaafar","year":"2019","unstructured":"Gaafar AG, Abo-Youssef AM, Khalaf MM, Abo-Saif AA (2019) Protective effects of vitamin D and losartan in complete Freund\u2019s adjuvant-induced arthritis in rats. Pak J Pharm Sci 32:593\u2013600","journal-title":"Pak J Pharm Sci"},{"key":"6672_CR95","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4103\/ijmr.IJMR_640_19","volume":"152","author":"TM Mostafa","year":"2020","unstructured":"Mostafa TM, Hegazy SK, Elshebini EM et al (2020) A comparative study on the anti-inflammatory effect of angiotensin-receptor blockers & statins on rheumatoid arthritis disease activity. Indian J Med Res 152:393\u2013400. https:\/\/doi.org\/10.4103\/ijmr.IJMR_640_19","journal-title":"Indian J Med Res"},{"key":"6672_CR96","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejphar.2015.08.026","volume":"765","author":"MG Fahmy Wahba","year":"2015","unstructured":"Fahmy Wahba MG, Shehata Messiha BA, Abo-Saif AA (2015) Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats. Eur J Pharmacol 765:307\u2013315. https:\/\/doi.org\/10.1016\/j.ejphar.2015.08.026","journal-title":"Eur J Pharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06672-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06672-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06672-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T19:42:57Z","timestamp":1673120577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06672-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["6672"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06672-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}